kanamycin a has been researched along with hoe 33342 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Green, MR; Werstuck, G | 1 |
Jiang, H; Schacht, J; Sha, SH | 1 |
2 other study(ies) available for kanamycin a and hoe 33342
Article | Year |
---|---|
Controlling gene expression in living cells through small molecule-RNA interactions.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; Benzimidazoles; Bisbenzimidazole; CHO Cells; Cricetinae; Drug Resistance, Microbial; Escherichia coli; Gene Expression Regulation; Kanamycin; Ligands; Molecular Sequence Data; Protein Biosynthesis; RNA; RNA, Messenger; Tobramycin; Transfection | 1998 |
NF-kappaB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity.
Topics: Aldehydes; Animals; Anti-Bacterial Agents; Auditory Threshold; Benzimidazoles; Blotting, Western; Calcium-Binding Proteins; Cell Cycle Proteins; Cell Death; Cell Fractionation; Cochlea; Cyclooxygenase Inhibitors; DNA Replication Timing; Drosophila Proteins; Drug Administration Schedule; Drug Interactions; Electrophoretic Mobility Shift Assay; Enzyme Activation; Hair Cells, Auditory; Hydroxybenzoates; Immunohistochemistry; Immunoprecipitation; Iron Chelating Agents; Kanamycin; Male; Membrane Glycoproteins; Mice; Mice, Inbred CBA; Molecular Chaperones; Nerve Tissue Proteins; NF-kappa B; Phosphorylation; Protective Agents; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Salicylates; Signal Transduction; Synaptotagmin I; Synaptotagmins; Time Factors; Tyrosine | 2005 |